Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Bay Area Medical Center
mi
from
Marinette, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Oconto Falls
mi
from
Oconto Falls, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
London Regional Cancer Program
mi
from
London,
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
London Regional Cancer Program
mi
from
London,
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology Services Foundation
mi
from
Scottsdale, AZ
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology Services Foundation
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
UC Irvine Health/Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
UC Irvine Health/Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Sutter Medical Center Sacramento
mi
from
Sacramento, CA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Sutter Medical Center Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Integrated Community Oncology Network-Florida Cancer Center Beaches
mi
from
Jacksonville Beach, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Integrated Community Oncology Network-Florida Cancer Center Beaches
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Baptist MD Anderson Cancer Center
mi
from
Jacksonville, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Baptist MD Anderson Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Integrated Community Oncology Network at Southside Cancer Center
mi
from
Jacksonville, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Integrated Community Oncology Network at Southside Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center South
mi
from
Jacksonville, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center South
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Jupiter Medical Center
mi
from
Jupiter, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Jupiter Medical Center
mi
from
Jupiter, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
21st Century Oncology-Orange Park
mi
from
Orange Park, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
21st Century Oncology-Orange Park
mi
from
Orange Park, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
21st Century Oncology-Palatka
mi
from
Palatka, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
21st Century Oncology-Palatka
mi
from
Palatka, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Integrated Community Oncology Network-Flager Cancer Center
mi
from
Saint Augustine, FL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Integrated Community Oncology Network-Flager Cancer Center
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Ingalls Memorial Hospital
mi
from
Harvey, IL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Anderson Regional Hospital/Cancer Center
mi
from
Anderson, IN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Anderson Regional Hospital/Cancer Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Franciscan Saint Francis Health-Beech Grove
mi
from
Beech Grove, IN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Franciscan Saint Francis Health-Beech Grove
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Reid Health
mi
from
Richmond, IN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
James Graham Brown Cancer Center, University of Louisville
mi
from
Louisville, KY
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
James Graham Brown Cancer Center, University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Union Hospital of Cecil County
mi
from
Elkton, MD
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Union Hospital of Cecil County
mi
from
Elkton, MD
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Borgess Medical Center
mi
from
Kalamazoo, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Borgess Medical Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Bronson Methodist Hospital
mi
from
Kalamazoo, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Bronson Methodist Hospital
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Lake Huron Medical Center
mi
from
Port Huron, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Lake Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Nebraska Methodist Hospital
mi
from
Omaha, NE
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Renown Regional Medical Center
mi
from
Reno, NV
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Renown Regional Medical Center
mi
from
Reno, NV
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Summa Barberton Hospital
mi
from
Barberton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Summa Barberton Hospital
mi
from
Barberton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Grandview Hospital
mi
from
Dayton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital - Dayton
mi
from
Dayton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials